Gemini Therapeutics, Inc. is acquired by Assenagon Asset Management S.A. for 66,467 shares (NASDAQ:GMTX)
The most recent filing that the company made with the Securities and Exchange Commission revealed that during the third quarter, Assenagon Asset Management S.A. increased …